Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis.

Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis. Adv Exp Med Biol. 2019;1164:73-87 Authors: Song BJ, Abdelmegeed MA, Cho YE, Akbar M, Rhim JS, Song MK, Hardwick JP Abstract The purpose of this review is to briefly summarize the roles of alcohol (ethanol) and related compounds in promoting cancer and inflammatory injury in many tissues. Long-term chronic heavy alcohol exposure is known to increase the chances of inflammation, oxidative DNA damage, and cancer development in many organs. The rates of alcohol-mediated organ damage and cancer risks are significantly elevated in the presence of co-morbidity factors such as poor nutrition, unhealthy diets, smoking, infection with bacteria or viruses, and exposure to pro-carcinogens. Chronic ingestion of alcohol and its metabolite acetaldehyde may initiate and/or promote the development of cancer in the liver, oral cavity, esophagus, stomach, gastrointestinal tract, pancreas, prostate, and female breast. In this chapter, we summarize the important roles of ethanol/acetaldehyde in promoting inflammatory injury and carcinogenesis in several tissues. We also review the updated roles of the ethanol-inducible cytochrome P450-2E1 (CYP2E1) and other cytochrome P450 isozymes in the metabolism of various potentially toxic substrates, and consequent toxicities, including carcinogenesis in different tissues. We also briefly describe the ...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research

Related Links:

Conditions:   Lung Cancer;   Non Small Cell Lung Cancer Intervention:   Sponsors:   Picomole Inc;   University of California, Irvine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Digestive System Neoplasms;   Thoracic Neoplasms Interventions:   Behavioral: Emotional skills;   Behavioral: Short free talk and relaxation Sponsors:   University Hospital, Lille;   SCALab UMR CNRS 9193 Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Breast Cancer Metastatic;   BRCA 1 Gene Mutation;   BRCA 2 Gene Mutation Intervention:   Drug: SC10914 Sponsor:   Jiangxi Qingfeng Pharmaceutical Co. Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer Intervention:   Drug: AK104 Sponsor:   Peking University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Genital Neoplasms, Female;   Urogenital Neoplasms;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Carcinoma, Ovarian Epithelial;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female;   Endocrine System Diseases;   Gonadal Disorders;   Carcinoma;   Bevaci...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Metastatic Prostate Cancer Interventions:   Behavioral: Exercise therapy + radiation therapy;   Radiation: Radiation therapy Sponsor:   Milton S. Hershey Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Behavioral: Postcard;   Behavioral: Small Gift;   Behavioral: Loss Frame and Fear Appeals Sponsor:   Geisinger Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Head and Neck Squamous Cell Carcinoma;   Malignant Solid Neoplasm Interventions:   Drug: Alisertib;   Biological: Pembrolizumab Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Prostate Cancer Interventions:   Diagnostic Test: PSMA PET/CT guided intensification of therapy;   Other: Control Arm Sponsors:   Centre hospitalier de l'Université de Montréal (CHUM);   Canadian Cancer Society Research Institute (CCSRI);   Lantheus Medical Imaging;   British Columbia Cancer Agency;   London Health Sciences Centre;   Princess Margaret Hospital, Canada;   Tom Baker Cancer Centre;   Mc Master University;   Institute of Healt...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Liposarcoma;   CRC;   Prostate Cancer;   Breast Neoplasms;   Adenocarcinoma of Lung;   Solid Tumors Interventions:   Drug: PF-07220060;   Combination Product: Letrozole;   Combination Product: Fulvestrant Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alcoholism | Biology | Cancer | Cancer & Oncology | Diets | Esophagus Cancer | Fatty Liver Disease (FLD) | Gastric (Stomach) Cancer | Gastroenterology | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Oral Cancer | Oral Cavity Cancer | Pancreas | Pancreatic Cancer | Research | Smokers | Toxicology | Urology & Nephrology